Federal Register #DEA-1736

DEA Notice: Import Registration Application for Controlled Substances by Veterans Pharmaceuticals, Inc.

This opportunity concerns the application by Veterans Pharmaceuticals, Inc. to import controlled substances for research and clinical trials, as published by the Drug Enforcement Administration (DEA) under the Department of Justice. - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - OEMs and Vendors: - Veterans Pharmaceuticals, Inc. (applicant for importer registration) - Products/Controlled Substances Requested: - Lysergic acid diethylamide (LSD) - Marihuana Extract - Marihuana - Tetrahydrocannabinols - Mescaline - 3,4-Methylenedioxyamphetamine - 5-Methoxy-N,N-dimethyltryptamine - Dimethyltryptamine - Psilocybin - Psilocyn - Methamphetamine - Purpose and Requirements: - Importation is strictly for research and clinical trials - No authorization for commercial sale or importation of finished dosage forms (FDA-approved or non-approved) - Only the listed substances and activities are permitted under this registration - Public comments and requests for hearings are invited from registered bulk manufacturers and applicants

Description

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic classes of controlled substances. The application includes a list of controlled substances such as Lysergic acid diethylamide, Marihuana Extract, and Methamphetamine, among others. The company plans to import these substances to support research and clinical trials. Comments or objections to the issuance of the proposed registration may be submitted electronically by July 30, 2026. Requests for a hearing on the application must also be filed by this date.

View original listing